Cronos Group

What it is

Cronos Group Inc. is a publicly traded cannabis company headquartered in Toronto, Ontario. It trades on both the Toronto Stock Exchange and the Nasdaq Global Market under the ticker CRON ^[1][2]. The company operates as a federally licensed producer under Canada's Cannabis Act and sells adult-use cannabis products in Canada, along with CBD products in the United States and limited international medical cannabis activity ^[1][3]. Cronos was originally incorporated as PharmaCan Capital Corp. in 2012 and rebranded as Cronos Group in 2016 ^[1].

Ownership and corporate structure

Cronos is an independent publicly traded company, but its single largest shareholder is Altria Group, the U.S. tobacco conglomerate that owns Philip Morris USA. In March 2019, Altria closed a roughly C$2.4 billion investment that gave it an approximately 45% equity stake in Cronos along with warrants that could increase that position ^[4][5]. As of subsequent filings, Altria has continued to be reported as the largest shareholder, though the exact percentage and warrant status has shifted over time and should be checked against current SEC and SEDAR+ filings ^[1][2]. Cronos's subsidiaries have historically included Cronos USA (which holds the Lord Jones CBD brand) and operating entities tied to its PEACE NATURALS production site in Stayner, Ontario ^[1].

Market and category focus

Cronos's primary revenue comes from the Canadian adult-use market, where it sells dried flower, pre-rolls, vapes, edibles, and concentrates ^[1]. The company also sells CBD products in the United States through Lord Jones, and has had medical cannabis or export arrangements in jurisdictions such as Israel, Germany, and Australia at various points ^[1][3]. Cronos has historically emphasized cannabinoid research and a partnership with Ginkgo Bioworks aimed at producing cultured cannabinoids through fermentation, though the commercial output of that program has been limited and the agreement was restructured ^[6].

Notable brands

Cronos's consumer-facing brands include:

• Spinach — the company's mainstream Canadian adult-use brand, covering flower, pre-rolls, vapes, and edibles. Spinach is widely distributed across provincial cannabis retailers and has appeared on Canadian retail sales rankings ^[1][7].
• PEACE NATURALS — one of the earliest Health Canada–licensed producers (licensed in 2013), now used by Cronos primarily as a medical cannabis brand ^[1][3].
• Lord Jones — a premium CBD wellness brand acquired by Cronos in 2019 for approximately US$300 million, sold in the U.S. market ^[8].

This is a description of the brand portfolio, not a recommendation. Product availability, formulations, and quality vary by SKU, batch, and province; check provincial retailer listings and current Certificates of Analysis.

Reputation, controversies, and regulatory issues

Cronos has had several material controversies that are part of the public record:

• Accounting restatement and SEC settlement. In 2021, Cronos restated previously issued financial statements for 2019 and interim 2020 periods after identifying issues with revenue recognition tied to bulk resin transactions ^[9]. In 2022, the U.S. Securities and Exchange Commission announced a settled action against Cronos in connection with these issues; Cronos agreed to a cease-and-desist order without admitting or denying the findings ^[10]. A former executive was separately charged ^[10].
• Stock volatility and impairments. Like other Canadian LPs, Cronos has recorded large goodwill and asset impairments since 2019 as the post-legalization Canadian market underperformed early projections; details are disclosed in the company's annual filings ^[1][2].
• Strategic shifts. Cronos has at times scaled back facilities and restructured its U.S. and international footprint. Readers should not rely on older press releases as a current description of operations.

These items are documented in regulatory filings and reporting; treat any newer claims (positive or negative) with the same skepticism and verify against primary sources.

Availability and legal-market notes

In Canada, Cronos's adult-use products (primarily under Spinach) are sold through provincial wholesalers and licensed retailers; availability varies by province and SKU ^[7]. PEACE NATURALS medical cannabis is sold directly to registered medical patients under Health Canada's medical access framework ^[3]. Lord Jones CBD products are sold in the U.S. under the regulatory framework that followed the 2018 U.S. Farm Bill, which legalized hemp-derived CBD federally but left product-specific FDA status unsettled ^[11]. International sales depend on local import rules and the company's current licensing in each jurisdiction — none of which should be assumed without checking.

What to verify before relying on brand claims

Before treating any Cronos marketing claim as fact:

1. Current ownership and Altria stake — check the latest Cronos 10-K/40-F and proxy filings on SEC EDGAR and SEDAR+ ^[2].
2. Licensing status — verify against Health Canada's list of licensed cultivators, processors, and sellers ^[3].
3. Product specifics — cannabinoid content, terpene profiles, and contaminants testing should be confirmed via the current batch Certificate of Analysis, not legacy marketing material.
4. Financial and operational claims — revenue, market share, and capacity figures should come from the most recent quarterly filing, not press releases.
5. Health and wellness claims for Lord Jones or any CBD product — the U.S. FDA has not approved CBD as a dietary supplement or for most therapeutic claims ^[11]. Strong evidence

This profile was last checked in 2025. Cannabis companies change rapidly; treat anything older than the current quarter as potentially stale.

Sources

How this page was made

Related

• Aurora Cannabis — Canadian licensed producer focused on medical cannabis at home and a major exporter to Eur...
• Canopy Growth — Canadian licensed cannabis producer with multiple consumer brands and a separate U.S.-focu...